IRIS Archives

Information and Referral and Internet Sightings

IRIS@LISTSERV.ICORS.ORG

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Sylvia Caras <[log in to unmask]>
Reply To:
Date:
Mon, 16 Aug 2010 08:32:28 -0700
Content-Type:
text/plain
Parts/Attachments:
text/plain (13 lines)
Pisgah Labs announced the May 18, 2010 issuance of US Patent 
7,718,649. This patent demystifies the physical states of Imipramine 
Pamoate drug substances. The patent also covers methods of 
manufacturing, purifying and use of the drug in pharmaceutical 
preparations and marks the first allowance in a related series of 
applications pending before the United States Patent and Trademark Office.

<http://www.therapeuticsdaily.com/news/article.cfm?contentValue=723405&contentType=newsarchive&channelID=26>http://www.therapeuticsdaily.com/news/article.cfm?contentValue=723405&contentType=newsarchive&channelID=26 



"People Who experience mood swings, fear, voices and visions"

ATOM RSS1 RSS2